Inhibition of streptococcal growth, F-ATPase and pyrophosphatase by diphosphonates.

Oral Microbiol Immunol

Department of Microbiology & Immunology, University of Rochester Medical Center, New York 14642-8672, USA.

Published: February 1995

1-Hydroxyethane-1,1-diphosphonate (EHDP) and a variety of other diphosphonates, and also pyrophosphate, at millimolar levels were found to inhibit the growth of Streptococcus mutans GS-5. Inhibition appeared to be due mainly to chelation of Mg2+ and could be readily reversed through addition of Mg2+, or less effectively, by other divalent cations. The trianionic forms of the diphosphonates or pyrophosphate were more effective inhibitors than the dianionic forms. Diphosphonates and pyrophosphate did not inhibit glycolysis by S. mutans, assayed in terms of glucose utilization, or arginolysis by Streptococcus rattus FA-1, assayed in terms of ammonia production. However, they did act as buffers to moderate pH changes. Diphosphonates also were inhibitors of the F-ATPase of S. mutans by complex mechanisms only partly reversible with divalent cations. They also were inhibitors of the pyrophosphatase of the organism. However, intact cells were impermeable to the compounds, and inhibition of cytoplasmic or membrane enzymes did not appear to be involved in growth inhibition.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-302x.1995.tb00117.xDOI Listing

Publication Analysis

Top Keywords

diphosphonates pyrophosphate
12
divalent cations
8
forms diphosphonates
8
assayed terms
8
diphosphonates
5
inhibition
4
inhibition streptococcal
4
streptococcal growth
4
growth f-atpase
4
f-atpase pyrophosphatase
4

Similar Publications

Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) affects all cardiac chambers to cause left ventricular (LV) deformation as well as left atrial (LA) remodeling and functional impairment. We investigated the associations of the LA volume index (LAVI):LV ejection fraction (LVEF) ratio with the increased risk of death, heart transplant, or LV assist device implantation (LVAD) in patients with ATTR-CM.

Methods: This was a retrospective cohort study involving 69 heart failure (HF) patients with ATTR-CM at an academic medical center between 1 November 2008 and 31 March 2024.

View Article and Find Full Text PDF

The current treatments for toxoplasmosis are only active against fast-growing tachyzoites, present in acute infections, with little effect on slow-growing bradyzoites within tissue cysts, present in latent chronic infections. The mitochondrion of is essential for its survival, and one of the major anti-parasitic drugs, atovaquone, inhibits the mitochondrial electron transport chain at the coenzyme Q:cytochrome c oxidoreductase site. Coenzyme Q (also known as ubiquinone [UQ]) consists of a quinone head and a lipophilic, isoprenoid tail that anchors UQ to membranes.

View Article and Find Full Text PDF

In recent years, growth hormone and insulin-like growth factors have become key regulators of bone metabolism and remodeling, crucial for maintaining healthy bone mass throughout life. Studies have shown that adult growth hormone deficiency leads to alterations in bone remodeling, significantly affecting bone microarchitecture and increasing fracture risk. Although recombinant human growth hormone replacement therapy can mitigate these adverse effects, improving bone density, and reduce fracture risk, its effectiveness in treating osteoporosis, especially in adults with established growth hormone deficiency, seems limited.

View Article and Find Full Text PDF
Article Synopsis
  • Renal fibrosis is a major issue in chronic kidney disease, and recent studies suggest that protein prenylation plays a role in its progression.
  • The research explored the protective effects of zoledronic acid (ZA) on kidney function in rats with chemically induced renal fibrosis, measuring several health indicators and protein levels.
  • Results showed that ZA significantly improved blood pressure, reduced markers of kidney damage and fibrosis, and preserved renal function by inhibiting a specific protein involved in the fibrosis process.
View Article and Find Full Text PDF

Introduction: Bisphosphonates (P-C-Ps) also called diphosphonates are the structural analogs of naturally occurring pyrophosphates. Bisphosphonates are traditionally used and shown to provide long-term success in the treatment and prevention of osteoporosis and other bone loss pathologies. Furthermore, bisphosphonates are gaining popularity in the present era of cancer therapeutics and prevention.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!